Alpha Tau Medical (DRTS) CFO trades 2,270 shares in exercise and sale

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. Chief Financial Officer Levy Raphi reported same-day share transactions involving the company’s Ordinary Shares. He exercised 2,270 shares at a price of $2.98 per share and sold 2,270 shares in an open-market sale at $14.0011 per share. Following these transactions, he directly held 90,180 Ordinary Shares.

Insider Trade Summary 10b5-1

Net Seller: 2,270 shares ($31,782)

Net Sell 2 txns

Insider Levy Raphi

Role Chief Financial Officer

Sold 2,270 shs ($32K)

Type	Security	Shares	Price	Value
Exercise	Ordinary Shares	2,270	$2.98	$7K
Sale	Ordinary Shares	2,270	$14.0011	$32K

Holdings After Transaction: Ordinary Shares — 92,450 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 2,270 shares Sale price: $14.0011 per share Shares exercised: 2,270 shares +3 more

6 metrics

Shares sold 2,270 shares Open-market sale of Ordinary Shares

Sale price $14.0011 per share Price for 2,270 Ordinary Shares sold

Shares exercised 2,270 shares Derivative exercise/conversion of Ordinary Shares

Exercise price $2.98 per share Exercise price for 2,270 shares

Shares held after 90,180 shares Direct ownership after transactions

Interim holdings 92,450 shares Direct holdings reported after exercise transaction

Key Terms

open-market sale, derivative exercise/conversion, Ordinary Shares, Form 4

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

Ordinary Shares financial

"security_title": "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 07:49 AM Accepted by SEC EDGAR 07/07/2026 - 07:49 AM Learn about SEC filing dates

FAQ

What insider activity did Alpha Tau Medical (DRTS) CFO Levy Raphi report?

Levy Raphi reported exercising and selling Ordinary Shares of Alpha Tau Medical. He exercised 2,270 shares at $2.98 and sold 2,270 shares in an open-market sale at $14.0011, with direct holdings reported at 90,180 shares afterward.

How many Alpha Tau Medical (DRTS) shares did the CFO sell and at what price?

The CFO sold 2,270 Ordinary Shares of Alpha Tau Medical. The sale was reported as an open-market transaction at a price of $14.0011 per share, according to the Form 4 insider trading disclosure data provided.

What was the exercise price for the Alpha Tau Medical (DRTS) shares acquired by the CFO?

The Form 4 shows the CFO exercised 2,270 Ordinary Shares at $2.98 per share. This transaction is labeled as a derivative exercise or conversion, distinct from the separate open-market sale reported for the same share amount.

How many Alpha Tau Medical (DRTS) shares does the CFO hold after these transactions?

After the reported transactions, the CFO is shown holding 90,180 Ordinary Shares directly. This figure reflects his direct ownership reported in the Form 4 following the exercise and open-market sale of 2,270 shares on the same date.

Does the Alpha Tau Medical (DRTS) Form 4 indicate open-market selling by the CFO?

Yes. The Form 4 labels one transaction as an open-market sale of 2,270 Ordinary Shares at $14.0011 per share. This is categorized as a sale transaction, separate from the derivative exercise reported for the same share quantity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Raphi

(Last) (First) (Middle)

C/O ALPHA TAU MEDICAL

PO BOX 45044

(Street)

JERUSALEM 9777605

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alpha Tau Medical Ltd. [ DRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/06/2026	07/06/2026	M		2,270	A	$2.98	92,450	D
Ordinary Shares	07/06/2026	07/06/2026	S		2,270	D	$14.0011	90,180	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Raphi Levy	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)